Neomend

Neomend

Neomend develops and manufactures surgical sealants based on its Progel hydrogel polymer technology, including pleural air-leak and vascular sealants. Bard acquired the Irvine-based company in 2012; FDA manufacturing records continued to identify Neomend in 2025.

Key facts

Company Operating StatusAcquired
Wellfound IDneomend